MICM
ZYME icon

Matthews International Capital Management’s Zymeworks ZYME Stock Holding History

Matthews International Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-129,700
Closed -$4.68M – 42
2020
Q2 		$4.68M Hold
129,700
– – 0.36% 28
2020
Q1 		$4.6M Buy
+129,700
New +$5.31M 0.3% 29

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Matthews International Capital Management's ZYME Position: Q3 2020 in Review

Matthews International Capital Management sold out of Zymeworks (ZYME) in Q3 2020, closing a stake of 129,700 shares — an estimated $4.68M sold.

Matthews International Capital Management first reported a position in ZYME in Q1 2020 and held it in 2 quarters. The position peaked at $4.68M in Q2 2020. 127 funds tracked by Wall St. Rank hold ZYME as of Q3 2020.

  • Matthews International Capital Management reported no remaining Zymeworks position as of Q3 2020 after selling out during the quarter.
  • Matthews International Capital Management sold 129,700 Zymeworks shares in Q3 2020, an estimated $4.68M.
  • Matthews International Capital Management first reported a position in Zymeworks in Q1 2020 and held it in 2 quarters.
  • Matthews International Capital Management's Zymeworks position peaked at $4.68M in Q2 2020.
  • 127 funds tracked by Wall St. Rank held Zymeworks as of Q3 2020.

Based on Matthews International Capital Management's 13F filing for Q3 2020, filed 5 Nov 2020.